Change - Announcement of Cessation::Passing of Chief Financial Officer

Issuer & Securities

Issuer/ Manager
QT VASCULAR LTD.
Securities
QT VASCULAR LTD. - SG2G82000008 - 5I0
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
19-May-2020 18:17:22
Status
New
Announcement Sub Title
Passing of Chief Financial Officer
Announcement Reference
SG200519OTHRP71X
Submitted By (Co./ Ind. Name)
Eitan Konstantino
Designation
Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor") in accordance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms. Gillian Goh, Director, Head of Continuing Sponsorship (Mailing Address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and Email: sponsorship@ppcf.com.sg).

Additional Details

Name Of Person
Randal Farwell
Age
61
Is effective date of cessation known?
Yes
If yes, please provide the date
15/05/2020
Detailed Reason (s) for cessation
Mr Randal Farwell passed away due to illness on 15 May 2020 after having been on leave of absence since 22 May 2019.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
Yes
If Yes, Please provide full details
The accounting and finance function of the Group will be overseen by Mr Kelvin Tong, the Group's Financial Controller and will be
supported by Ms Gina La, the Director of Finance and a team of experienced finance staff.
Date of Appointment to current position
01/08/2013
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
1
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
1
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Financial Officer
Role and responsibilities
All accounting and financial matters of the Group.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil.
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Deemed interested in 49 ordinary shares held in the name of OCBC Securities Private Ltd.
Past (for the last 5 years)
Nil
Present
Nil